Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674119010 | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3674121017 | Benzocaine 10 mg and cetylpyridinium chloride 1.4 mg oromucosal lozenge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Compound anesthetic topical preparation | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Local anesthetic (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing cetylpyridinium (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing benzocaine (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Benzocaine (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Cetylpyridinium | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Cationic surfactant (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Skin anti-infective | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing benzocaine and cetylpyridinium (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | produit contenant du cétylpyridinium sous forme oropharyngée | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | produit contenant de la benzocaïne sous forme oropharyngée | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Lozenge | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Oromucosal lozenge | true | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product manufactured as oromucosal dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Benzocaine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator value | 1.4 | false | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator value | 10 | false | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance (attribute) | Cetylpyridinium chloride (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Cetylpyridinium chloride (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance (attribute) | Benzocaine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Benzocaine and cetylpyridinium only product in oromucosal dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets